This paper is a report of a 34-year-old man with chronic renal failure undergoing Continuous Ambulatory Peritoneal Dialysis which developed peritonitis due to Geotricum candidum. The diagnosis was established by culture of dialysis fluid. The purpose of this report is to provide data on a fungal peritonitis due to a non-common agent.
Introduction
Peritonitis is the main complication of Continuous Ambulatory Peritoneal Dialysis (CAPD) [1] [2] [3] . Bacterias are responsible for the main part of the cases, peritonitis by fungi is non-frequent, only about 1% to 23% of the reported series.
Candida is the most common agent, implicated in 80% -90% of the fungi peritonitis cases. Kavanagh in a study realized from 1999 to 2002 in Scotland concluded that fungi infections regarded 3.4% of all reported cases [4] . In Latin America, Gadola found 2 cases of fungi in 144 cases of peritonitis. Russi et al., in a 5-year study, in 149 cases of peritonitis found that 8.1% of cases were related to fungi. Candida albicans was isolated in 6 cases [2] . In India Indhumathi et al., on a 7 year period found 30 cases of fungal peritonitis in CAPD [5] . The common fungus was Candida species (50%). In Argentina, in a period of 25 years, 183 How to cite this paper: Garza, J.R.C., Miranda, R.S.C., Garza, A.M.C., Texis, A.P.E., Díaz, E.G. and Juárez, U.S. (2018) Peritoni-Introduction of fungi to peritoneal cavity is due to contamination by contact or direct extension of infection in the catheter outlet through the subcutaneous tunnel and to the peritoneum. The fungi enter the peritoneal cavity through intraluminal and periluminal ways, going through the intestinal mucous membrane, and through hematogenous ways, starting from a distant fungal infection.
[28] The importance of this type of peritonitis depends on the morbidity and mortality and as the main cause of technical failure [1] Fluconazole has some advantages in relation to other antifungals, its versatility to be applied orally or intraperitoneal, its bioavailability in peritoneal cavity when administered orally or intravenously and good tolerance are the main benefits.
It must be noted that ideal antifungal therapy has not been yet identified, this includes the dosification, routes of administration or the treatment time, even though it has been established a minimum of 2 weeks. Prophylaxis with Fluconazole (100 mg/day), Ketoconazole (200 mg/day) or Nystatin has demonstrated its effectiveness in the reducing the incidence of fungal peritonitis in patients Geotrichum candidum. The patient was admitted in December due to edema, abdominal pain and cloudy dialyzate, during physical examination peritoneal irritation was found, cell counts showed 74 cell/mm 3 with an increase in polymorphs (80%), direct microscopy and Gram stain were negative. The catheter was retired at the eight day of hospitalization due to the persistence of the symptoms, despite antimicrobial treatment. He was discharged asymptomatic.
Case Report
Dialysis fluid sent to ICBUAP was reported as Geotrichum candidum growth.
He was admitted in January 1994 for new peritoneal dialysis which failed due to peritoneal septum and therefore transferred for hemodialysis.
After the transfer of the patient, contact with him was lost, his health status is currently unknown.
Discussion
Geotrichosis is an infrequent opportunistic mycosis caused by yeasts. Description of the organism in eczematous dermatitis during 1935 by Cifern and Redaelli probably represent isolation of normal flora from a pathogenic process of different etiology. Geotrichosis is usually secondary to some other debilitation, such as tuberculosis, a complication of steroid therapy, diabetic patients, AIDS, or an oncological pathology, in overall presenting in the immunocompromised host [38] . André et al. reported the case of septicemia due to Geotrichum candidum in a child with hepatoblastoma [39] . Ng and his group reported a disseminated G. candidum infection in a 4-year-old patient with acute lymphoblastic leukemia [40] . In a study reported by Bonifaz et al., in 12 cases of oral geotrichosis, found 8 diabetic patients, 2 patients with acute lymphoblastic leukemia, 1 patient with AIDS and a patient with Hodgkin's lymphoma [34] . Myint's group described a case of postoperative fungal endophthalmitis due to G. candidum in a diabetic patient [37] .
Schnoor isolated the fungus in 29% of 314 stool specimens obtained from healthy people. On another study, based on samples from sputum, feces, urine and vaginal secretions of 2643 patients, 18% to 31% specimens were isolated, though they were not associated to another specific sickness [41] . ciation as a microorganism with a documented history in dairy products [42] .
In an attempt to understand the pathogenicity of fungi in general, special emphasis has been made on their ability to developed biofilms, not only as protection against the environment but as a special infectious reservoir that can lead to systemic infection.
In recent research, developed exclusively on C. albicans, by Harriott and Noverr, proved that biofilms had the capacity to attach on medical devices, such as catheters or mucosal host tissues, which provide an excellent environment for their development [43] . of the patients [44] . Therefore, it would be correct to hypothesize that G. candidum uses the same molecular components to induce damage to the host.
We believe that in our case, the first episode of peritonitis was acquired during manipulation of dialysis bag changes, it must be noted that in the decade of the PMN rather than the absolute WBC count to diagnose peritonitis, and a proportion above 50% is strong evidence of peritonitis, even if the absolute WBC count is less than 100/μL. In our case, the only criterion not reached was that of cellularity greater than 100 cells, probably due to rapid drainage of the liquid, covering the rest of the criteria indicated to establish the diagnosis.
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